CN101810803A - Chinese medicinal composition for treating hematuria and preparation method thereof - Google Patents
Chinese medicinal composition for treating hematuria and preparation method thereof Download PDFInfo
- Publication number
- CN101810803A CN101810803A CN201010182016A CN201010182016A CN101810803A CN 101810803 A CN101810803 A CN 101810803A CN 201010182016 A CN201010182016 A CN 201010182016A CN 201010182016 A CN201010182016 A CN 201010182016A CN 101810803 A CN101810803 A CN 101810803A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- herba
- hematuria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treating hematuria and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: amur corktree bark, gypsum, anemarrhena asphodeloides bunge, cortex lycii radicis, Mongolian snakegourd root, common lophatherum herb, reed rhizome, gardenia, figwort root, tree peony bark, Sinkiang arnebia root, red paeony root, honeysuckle flower, dandelion, Chinese arborvitae twig, charred sanguisorba root, glabrous greenbrier rhizome, Indian buead, oriental waterplantain rhizome, plantain seed, Japanese climbing fern spore, pyrrosia leaf, turtle shell, rosewood heart wood, medlar and the like. The Chinese medicinal composition can be prepared into any common oral preparation by the conventional Chinese medicinal preparation method. The Chinese medicinal composition can obviously improve symptoms such as hematuria, gross hematuria, reddish yellow urine, brown urine, and scanty dark urine, and related diseases such as nephritis, urinary tract infection, urinary calculus and renal tuberculosis and the like. The Chinese medicinal composition has the advantages of exact clinical effects, obvious curative effect, quick response, low cost, basically no toxic or side effects and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of hematuria.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment hematuria of crude drug with the Chinese herbal medicine.
Background technology
Hematuria is meant and is mixed with blood in the urine, or descends with clot is mingled with, and do not have the hardship of pain more.Hematuria one card, doctor trained in Western medicine think, during the every high power field of microscopy in normal person's the centrifugal Urine sediments analyzer 〉=3 erythrocyte, promptly is called hematuria.Hematuria usually is that the disease by urinary organs causes, it is a very important disease signal, the damage at any one position, inflammation, tumor etc. all can cause hematuria in people's the urinary system, and the common disease of hematuria that causes has various nephritis, urinary system infection, hemorrhagic cystitis, urinary system calculus, renal tuberculosis, tumor of kidney, kidney and injury of urethra or the like.In recent years the clinical onset rate has the trend of continuous rising.
Modern medicine is at clinical a certain symptom treatment, often fall flat, can not find suitable Therapeutic Method, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment hematuria, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out cooling blood for hemostasis, clearing away heat and promoting diuresis, dissipating blood stasis, antidotal natural plant,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment hematuria that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
?
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment hematuria of evident in efficacy, with low cost, almost non-toxic side effect is provided.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of hematuria of the present invention, the component of main following weight portion is formed:
1～120 part of Cortex Phellodendri, 1～300 part of Gypsum Fibrosum, 1～100 part of the Rhizoma Anemarrhenae, 1～120 part of Cortex Lycii, 1～150 part of Radix Trichosanthis, 1～100 part of Herba Lophatheri, 1～100 part of Rhizoma Phragmitis, 1～100 part of Fructus Gardeniae, 1～100 part of Radix Scrophulariae, 1～120 part of Radix Rehmanniae, 1～120 part of Cortex Moutan, 1～100 part of Radix Arnebiae (Radix Lithospermi), 1～120 part of Radix Paeoniae Rubra, 1～120 part of Flos Lonicerae, 1～100 part of Herba Violae, 1～100 part of Herba Taraxaci, 1～120 part of Platycladi Cacumen carbonisatum, 1～120 part of charred Radix Sanguisorbae, 1～120 part of Rhizoma Smilacis Glabrae, 1～100 part of Herba Lobeliae Chinensis, 1～150 part in Poria, 1～120 part of Rhizoma Alismatis, 1～100 part of Semen Plantaginis, 1～100 part of Semen Coicis, 1～150 part of Spora Lygodii, 1～100 part of Folium Pyrrosiae, 1～100 part of 1～100 part of Herba Polygoni Avicularis of Herba Dianthi, 1～120 part of Radix Ophiopogonis, 1～120 part of Radix Asparagi, 1～120 part of Fructus Lycii, 1～100 part of Fructus Ligustri Lucidi, 1～50 part of Carapax Trionycis, 1～50 part of Carapax et Plastrum Testudinis.
Be preferably:
30 parts of Cortex Phellodendris, 100 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Cortex Lycii, 50 parts of Radix Trichosanthis, 25 parts of Herba Lophatheris, 30 parts of Rhizoma Phragmitiss, 20 parts of Fructus Gardeniaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 20 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Paeoniae Rubra, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Herba Taraxacis, 100 parts of Platycladi Cacumen carbonisatum, 50 parts of charred Radix Sanguisorbae, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Lobeliae Chinensis, 100 parts in Poria, 30 parts of Rhizoma Alismatis, 20 parts of Semen Plantaginiss, 50 parts of Semen Coiciss, 30 parts of Spora Lygodii, 30 parts of Folium Pyrrosiaes, 25 parts of 25 parts of Herba Polygoni Avicularis of Herba Dianthi, 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 30 parts of Fructus Lycii, 20 parts of Fructus Ligustri Lucidi, 10 parts of Carapax Trionycis, 10 parts of Carapax et Plastrum Testudiniss.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1～120 part of Pericarpium Citri Reticulatae, 1～100 part of Rhizoma Cyperi, 1～120 part of Fructus Toosendan, 1～100 part of Endothelium Corneum Gigeriae Galli, 1～120 part of Fructus Setariae Germinatus, 1～100 part of Radix Cirsii Japonici, 1～100 part of Herba Cirsii, 1～120 part of Rhizoma Imperatae, 1～50 part of Pseudobulbus Bletillae (Rhizoma Bletillae), 1～50 part of Crinis Carbonisatus, 1～100 part of Lignum Dalbergiae Odoriferae, 1～100 part of charred Petiolus Trachycarpi, 1～100 part of Pulvis Fumi Carbonisatus, 1～100 part of Radix Angelicae Sinensis, 1～100 part of the Radix Paeoniae Alba, 1～120 part of Radix Adenophorae (Radix Glehniae), 1～100 part of Rhizoma Polygonati Odorati.
Be preferably:
30 parts of Pericarpium Citri Reticulataes, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 20 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Fructus Setariae Germinatuss, 15 parts of Radix Cirsii Japonicis, 15 parts of Herba Cirsiis, 30 parts of Rhizoma Imperataes, 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 15 parts of Crinis Carbonisatus, 20 parts of Lignum Dalbergiae Odoriferaes, 30 parts of charred Petiolus Trachycarpi, 20 parts of Pulvis Fumi Carbonisatuss, 30 parts of Radix Angelicae Sinensis, 20 parts of the Radix Paeoniae Albas, 20 parts of Radix Adenophorae (Radix Glehniae), 15 parts of Rhizoma Polygonati Odorati.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to the hematuria patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 30 parts of Cortex Phellodendris, 100 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Cortex Lycii, 50 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 20 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Paeoniae Rubra, 30 parts of Flos Loniceraes, 100 parts of Platycladi Cacumen carbonisatum, 50 parts of charred Radix Sanguisorbae, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Lobeliae Chinensis, 100 parts in Poria, 30 parts of Rhizoma Alismatis, 20 parts of Semen Plantaginiss, 50 parts of Semen Coiciss, 30 parts of Spora Lygodii, 30 parts of Folium Pyrrosiaes, 25 parts of 25 parts of Herba Polygoni Avicularis of Herba Dianthi, 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 30 parts of Fructus Lycii, 15 parts of Crinis Carbonisatus, 20 parts of Lignum Dalbergiae Odoriferaes, 30 parts of charred Petiolus Trachycarpi, 20 parts of Pulvis Fumi Carbonisatuss.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 30 parts of Cortex Phellodendris, 100 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Cortex Lycii, 50 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 20 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Paeoniae Rubra, 30 parts of Flos Loniceraes, 100 parts of Platycladi Cacumen carbonisatum, 50 parts of charred Radix Sanguisorbae, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Lobeliae Chinensis, 100 parts in Poria, 30 parts of Rhizoma Alismatis, 20 parts of Semen Plantaginiss, 50 parts of Semen Coiciss, 30 parts of Spora Lygodii, 30 parts of Folium Pyrrosiaes, 25 parts of 25 parts of Herba Polygoni Avicularis of Herba Dianthi, 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 30 parts of Fructus Lycii, 15 parts of Crinis Carbonisatus, 20 parts of Lignum Dalbergiae Odoriferaes, 30 parts of charred Petiolus Trachycarpi, 20 parts of Pulvis Fumi Carbonisatuss.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material by following weight portion: 30 parts of Cortex Phellodendris, 100 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Cortex Lycii, 50 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 20 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Paeoniae Rubra, 30 parts of Flos Loniceraes, 100 parts of Platycladi Cacumen carbonisatum, 50 parts of charred Radix Sanguisorbae, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Lobeliae Chinensis, 100 parts in Poria, 30 parts of Rhizoma Alismatis, 20 parts of Semen Plantaginiss, 50 parts of Semen Coiciss, 30 parts of Spora Lygodii, 30 parts of Folium Pyrrosiaes, 25 parts of 25 parts of Herba Polygoni Avicularis of Herba Dianthi, 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 30 parts of Fructus Lycii, 15 parts of Crinis Carbonisatus, 20 parts of Lignum Dalbergiae Odoriferaes, 30 parts of charred Petiolus Trachycarpi, 20 parts of Pulvis Fumi Carbonisatuss.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material by following weight portion: 30 parts of Cortex Phellodendris, 100 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Cortex Lycii, 50 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 20 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Paeoniae Rubra, 30 parts of Flos Loniceraes, 100 parts of Platycladi Cacumen carbonisatum, 50 parts of charred Radix Sanguisorbae, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Lobeliae Chinensis, 100 parts in Poria, 30 parts of Rhizoma Alismatis, 20 parts of Semen Plantaginiss, 50 parts of Semen Coiciss, 30 parts of Spora Lygodii, 30 parts of Folium Pyrrosiaes, 25 parts of 25 parts of Herba Polygoni Avicularis of Herba Dianthi, 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 30 parts of Fructus Lycii, 15 parts of Crinis Carbonisatus, 20 parts of Lignum Dalbergiae Odoriferaes, 30 parts of charred Petiolus Trachycarpi, 20 parts of Pulvis Fumi Carbonisatuss.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material by following weight portion: 30 parts of Cortex Phellodendris, 100 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Cortex Lycii, 50 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 20 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Paeoniae Rubra, 30 parts of Flos Loniceraes, 100 parts of Platycladi Cacumen carbonisatum, 50 parts of charred Radix Sanguisorbae, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Lobeliae Chinensis, 100 parts in Poria, 30 parts of Rhizoma Alismatis, 20 parts of Semen Plantaginiss, 50 parts of Semen Coiciss, 30 parts of Spora Lygodii, 30 parts of Folium Pyrrosiaes, 25 parts of 25 parts of Herba Polygoni Avicularis of Herba Dianthi, 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 30 parts of Fructus Lycii, 15 parts of Crinis Carbonisatus, 20 parts of Lignum Dalbergiae Odoriferaes, 30 parts of charred Petiolus Trachycarpi, 20 parts of Pulvis Fumi Carbonisatuss.
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into
Normal concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating hematuria of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 211 routine patients altogether, wherein male 135 examples, women 76 examples; The oldest person 76 years old, the age reckling has only 5 years old.
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 3 courses of treatment altogether.
Three, therapeutic evaluation standard
Cure: sign and symptom are improved fully, and be in high spirits.
Produce effects: sign and symptom are significantly improved, and spirit is fine.
Effectively: sign and symptom change, and random thoughts have discomfort slightly, but can accept.
Invalid: sign does not have change, symptom such as preceding.
Four, model case:
1, Zhang, man, 35 years old.
The patient slight hematuria phenomenon occurred and is not present to the mind before half a year, think be overworked due to, I had never expected that 2 months postabdomens have an intense pain suddenly, find that also own urine color is a bit unusual, just see the doctor to the clinic, urine sample inspection discovery is a hematuria.The back symptom of taking medicine turns for the better by and large, but how long does not have, and not but hematuria occurs, symptoms such as malaise, abdominal pain also do not occurred, then has sought the traditional Chinese medical science.
Took Chinese medicine composition of the present invention 10, the hematuria transference cure, abdominal pain is obviously alleviated.The clothes Chinese medicine composition of the present invention 20 days that continues, hematuria and stomachache sense all disappear, antisecosis is energetic, patient's recovery from illness, after follow up a case by regular visits to and do not have recurrence.
2, thunder, man, 8 years old, Shandong nationality.
Just stepped into primary school soon, two ankle joint swelled and ache unbearably 2 years repeatedly, influence study.One disease does not heal, and presents hematuria again, and the family circle is very much worried, asks that everywhere the doctor asks medicine.Human health screening: two ankle swelling, the tenderness positive.Gross hematuria.F VIII: C2.2%, ultrasound diagnosis: left renal pelvis calculus.Diagnosis: hemophilia A, two ankle joint inflammation, left renal pelvis calculus hematuria.Consider that the patient is young, Chinese traditional treatment is sought in decision.
Took Chinese medicine composition of the present invention 5 days, arthralgia disappears, and hematuria stops.Continue and obeyed Chinese medicine composition of the present invention 20, symptom all disappears, and can normally go to school.It is steady to follow up a case by regular visits to 4 months state of an illness.
3, Zhang, man, 74 years old, retired worker.
Patient body is fine always, finds that a few days ago own urine has color, violated after thinking fatigue, and also superficial when urinating, just do not take notice of.Hasten after son finds to be with him to examination in hospital, the doctor is PSA and checks and B ultrasonic.The result is shown as: prostatic hyperplasia.Effect is not clearly behind the western medical treatment, so seek Chinese traditional treatment.
Took Chinese medicine composition of the present invention 10, the hematuria transference cure.Continue and obeyed Chinese medicine composition of the present invention 30, patient's spirit is good, and the doctor trained in Western medicine inspection shows that every index is normal, and patient's recovery from illness does not have recurrence so far.
4, Wu, man, 51 years old, retired cadre.
The patient found urine protein (--) ERY (3+) during health check-up before 2 years, the anxious dysurea of anuria pollakiuria, unparalleled lower limb purpura, lumbago, arthralgia, no alopecia, no oral ulcer is gone to a doctor then in local hospital, by " acute nephritis ", give and anti-infective therapy, take a turn for the better and leave hospital, after do not take medicine again.In August in the same year, gross hematuria appears in the patient after fatigue, and the aching and tired discomfort of sensation lower back is not given attention, and in November in the same year, the aching and tired discomfort of the conscious lower back of patient increases the weight of, and seeks Chinese traditional treatment.Tcm diagnosis is hematuria, failure of the spleen to keep the blood flowing within the vessels.
Took Chinese medicine composition of the present invention 10, the hematuria transference cure, the aching and tired sense of lower back is alleviated.Continue and obeyed Chinese medicine composition of the present invention 10, the aching and tired sense of lower back disappears, and does not occur gross hematuria again.The clothes Chinese medicine composition of the present invention that continues was consolidated 20, patient's recovery from illness, and spirit is good.
5, model, woman, 19 years old, student.
Patient's dysurea, urgent micturition, hematuria, have the blood streak that first quarter moon is arranged, remove examination in hospital, the doctor says so because urinary system infection causes.Treat a week, the dysurea symptom has slightly and alleviates.Under mother's suggestion, seek Chinese traditional treatment.
Took Chinese medicine composition of the present invention 5, the symptom of dysurea, urgent micturition, hematuria disappears substantially.The clothes Chinese medicine composition of the present invention that continues was consolidated 15, and symptom all disappears, patient's recovery from illness.
6, flourish certain, woman, 9 years old.
Patient 9 years old repeatedly suffers from urethritis, does urinary system before half a year and checks comprehensively, does not have organic problem.Occurred hematuria before 1 week again, and when morbidity is with stomachache.Urine test occult blood 1+, other is normal, blood count leukocyte 11.7, intermediate cell percentage ratio 9.1, lymphocyte absolute value 5.2, intermediate value cell absolute value 1.1, other are normal, beat short stopping 0.3, after again the urine test occult blood+-, leukocyte+-, the doctor also is unable to explain clearly it is what disease, only said and observed again in a week, opened a little kidney inflammation tablets, the amoxicillin.
Took Chinese medicine composition of the present invention 5, the hematuria remission, the abdominal pain sense alleviates.Continue and obeyed Chinese medicine composition of the present invention 25, hematuria and stomachache are felt all disappearances, and is happy, receives to increase.The clothes pharmaceutical composition after treatment of the present invention 15 days that continues, patient's recovery from illness, after follow up a case by regular visits to and do not have recurrence.
7, lucky certain, man, 39 years old.
Rising with the sun urine has omnidistance hematuria, and lower abdomen has intermittent distending pain, do B ultrasonic have prostate to increase＜42MM*33MM〉other are normal.Urine examination nitrite＜NIT〉positive＜+〉, occult blood＜ERY〉300.00, leukocyte＜LEU〉＜LEU〉25.00, the urine erythrocyte microscopy ++ ++.Doctor's suggestion is CD and is checked, but expense is very high, asks the traditional Chinese medical science then.
Took Chinese medicine composition of the present invention 7, the hematuria remission, lower abdomen is little to expand.Continue and obeyed Chinese medicine composition of the present invention 15, hematuria and this disappearance of lower abdomen pain with distension sensillary base.Continue and obeyed Chinese medicine composition of the present invention 30, sings and symptoms complete obiteration, patient's recovery from illness.
8, multitude, woman, 23 years old.
Patient's readme has pain after the urine, with lower abdomen pain, also have the blood streak sometimes, and own sensation should be a urinary system infection, after oral " nitrofurantoin ", and DeGrain, symptom is still sought curing and is treated.The patient does not have other medical history.
Took Chinese medicine composition of the present invention 5, dysurea remission, lower abdomen pain relief.Continue and obeyed Chinese medicine composition of the present invention 15, hematuria dysurea and stomachache disease disappear substantially.Continue and obeyed Chinese medicine composition of the present invention 15, transference cure, patient's recovery from illness.
Five, therapeutic outcome:
In the 211 routine cases of being accepted for medical treatment,, wherein cure 85 examples through treatment in 3 months, produce effects 67 examples, effective 40 examples, invalid 19 examples, total effective rate reaches 90%.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment hematuria patient.
Claims (7)
1. Chinese medicine composition for the treatment of hematuria is characterized in that: mainly contain following bulk drugs and form:
1～120 part of Cortex Phellodendri, 1～300 part of Gypsum Fibrosum, 1～100 part of the Rhizoma Anemarrhenae, 1～120 part of Cortex Lycii, 1～150 part of Radix Trichosanthis, 1～100 part of Herba Lophatheri, 1～100 part of Rhizoma Phragmitis, 1～100 part of Fructus Gardeniae, 1～100 part of Radix Scrophulariae, 1～120 part of Radix Rehmanniae, 1～120 part of Cortex Moutan, 1～100 part of Radix Arnebiae (Radix Lithospermi), 1～120 part of Radix Paeoniae Rubra, 1～120 part of Flos Lonicerae, 1～100 part of Herba Violae, 1～100 part of Herba Taraxaci, 1～120 part of Platycladi Cacumen carbonisatum, 1～120 part of charred Radix Sanguisorbae, 1～120 part of Rhizoma Smilacis Glabrae, 1～100 part of Herba Lobeliae Chinensis, 1～150 part in Poria, 1～120 part of Rhizoma Alismatis, 1～100 part of Semen Plantaginis, 1～100 part of Semen Coicis, 1～150 part of Spora Lygodii, 1～100 part of Folium Pyrrosiae, 1～100 part of 1～100 part of Herba Polygoni Avicularis of Herba Dianthi, 1～120 part of Radix Ophiopogonis, 1～120 part of Radix Asparagi, 1～120 part of Fructus Lycii, 1～100 part of Fructus Ligustri Lucidi, 1～50 part of Carapax Trionycis, 1～50 part of Carapax et Plastrum Testudinis.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
30 parts of Cortex Phellodendris, 100 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Cortex Lycii, 50 parts of Radix Trichosanthis, 25 parts of Herba Lophatheris, 30 parts of Rhizoma Phragmitiss, 20 parts of Fructus Gardeniaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 20 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Paeoniae Rubra, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Herba Taraxacis, 100 parts of Platycladi Cacumen carbonisatum, 50 parts of charred Radix Sanguisorbae, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Lobeliae Chinensis, 100 parts in Poria, 30 parts of Rhizoma Alismatis, 20 parts of Semen Plantaginiss, 50 parts of Semen Coiciss, 30 parts of Spora Lygodii, 30 parts of Folium Pyrrosiaes, 25 parts of 25 parts of Herba Polygoni Avicularis of Herba Dianthi, 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 30 parts of Fructus Lycii, 20 parts of Fructus Ligustri Lucidi, 10 parts of Carapax Trionycis, 10 parts of Carapax et Plastrum Testudiniss.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
1～120 part of Pericarpium Citri Reticulatae, 1～100 part of Rhizoma Cyperi, 1～120 part of Fructus Toosendan, 1～100 part of Endothelium Corneum Gigeriae Galli, 1～120 part of Fructus Setariae Germinatus, 1～100 part of Radix Cirsii Japonici, 1～100 part of Herba Cirsii, 1～120 part of Rhizoma Imperatae, 1～50 part of Pseudobulbus Bletillae (Rhizoma Bletillae), 1～50 part of Crinis Carbonisatus, 1～100 part of Lignum Dalbergiae Odoriferae, 1～100 part of charred Petiolus Trachycarpi, 1～100 part of Pulvis Fumi Carbonisatus, 1～100 part of Radix Angelicae Sinensis, 1～100 part of the Radix Paeoniae Alba, 1～120 part of Radix Adenophorae (Radix Glehniae), 1～100 part of Rhizoma Polygonati Odorati.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
30 parts of Pericarpium Citri Reticulataes, 30 parts of Rhizoma Cyperi, 30 parts of Fructus Toosendans, 20 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Fructus Setariae Germinatuss, 15 parts of Radix Cirsii Japonicis, 15 parts of Herba Cirsiis, 30 parts of Rhizoma Imperataes, 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 15 parts of Crinis Carbonisatus, 20 parts of Lignum Dalbergiae Odoriferaes, 30 parts of charred Petiolus Trachycarpi, 20 parts of Pulvis Fumi Carbonisatuss, 30 parts of Radix Angelicae Sinensis, 20 parts of the Radix Paeoniae Albas, 20 parts of Radix Adenophorae (Radix Glehniae), 15 parts of Rhizoma Polygonati Odorati.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation treatment hematuria medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101820160A CN101810803B (en) | 2010-05-25 | 2010-05-25 | Chinese medicinal composition for treating hematuria and use of prepared medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101820160A CN101810803B (en) | 2010-05-25 | 2010-05-25 | Chinese medicinal composition for treating hematuria and use of prepared medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101810803A true CN101810803A (en) | 2010-08-25 |
| CN101810803B CN101810803B (en) | 2011-11-09 |
Family
ID=42618264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101820160A Expired - Fee Related CN101810803B (en) | 2010-05-25 | 2010-05-25 | Chinese medicinal composition for treating hematuria and use of prepared medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101810803B (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102228633A (en) * | 2011-06-24 | 2011-11-02 | 暨南大学 | Traditional Chinese medicine for treating blood heat and toxic type nosebleed of children and preparation method thereof |
| CN102526413A (en) * | 2011-12-23 | 2012-07-04 | 鞠富霞 | Bladder care irrigation solution and preparation method thereof |
| CN102793902A (en) * | 2012-08-03 | 2012-11-28 | 郭卫东 | Preparation method for traditional Chinese medicine used for treatment of kidney and yin deficient type acute glomerulonephritis |
| CN102836352A (en) * | 2012-09-10 | 2012-12-26 | 曹培琳 | Medicament for treating hemorrhagic disease |
| CN102908467A (en) * | 2011-08-04 | 2013-02-06 | 孙斌 | Traditional Chinese medicine for treating hematuria |
| CN102988706A (en) * | 2012-10-30 | 2013-03-27 | 严中明 | Prescription of traditional Chinese medicine for treating hematuria |
| CN102988800A (en) * | 2012-10-30 | 2013-03-27 | 严中明 | Traditional Chinese medicine composition for treating hematuria and use method thereof |
| CN103330876A (en) * | 2013-07-19 | 2013-10-02 | 苏州市天灵中药饮片有限公司 | Decoction for curing cystitis |
| CN103550641A (en) * | 2013-11-13 | 2014-02-05 | 杨玉贵 | Kidney essence pill formula for treating chronic pyelonephritis and preparation method of kidney essence pill |
| JP2014159408A (en) * | 2013-01-22 | 2014-09-04 | Kao Corp | Overactive bladder preventing or improving agent |
| CN104027617A (en) * | 2014-05-15 | 2014-09-10 | 当涂县科辉商贸有限公司 | Traditional Chinese medicine composition for treating urinary tract infection |
| CN104207130A (en) * | 2014-09-16 | 2014-12-17 | 四川众鼎中药发展有限公司 | Food, health product or pharmaceutical composition with effects of clearing heat and freeing strangury |
| CN104258217A (en) * | 2014-10-16 | 2015-01-07 | 禤燕华 | Traditional Chinese medicine composition for treating hematuria |
| CN104606588A (en) * | 2015-02-03 | 2015-05-13 | 强红艳 | Pharmaceutical composition for treating urinary tract infection |
| CN104606555A (en) * | 2015-02-05 | 2015-05-13 | 范巧兰 | Heat-clearing and toxicity-removing medicine for treating exercise-induced hematuria and preparation |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101765988B1 (en) * | 2014-02-14 | 2017-08-07 | 최원형 | Anti-tuberculosis composition for treating or preventing tuberculosis comprising Melia azedarach L. extracts and fractions thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1225829A (en) * | 1998-12-28 | 1999-08-18 | 张芳芳 | Chinese preparatory medicine for treating haematuria, urinary protein and urinary obstruction |
| CN1689615A (en) * | 2004-04-21 | 2005-11-02 | 范崔生 | Bleeding arresting Chinese medicinal composition and its preparation method |
| CN101480457A (en) * | 2008-12-19 | 2009-07-15 | 重庆市合川区生产力促进中心 | Chinese medicinal composition for treating hematuria |
| CN101623431A (en) * | 2008-07-08 | 2010-01-13 | 张成赟 | Chinese medicinal composition for treating hematuria |
-
2010
- 2010-05-25 CN CN2010101820160A patent/CN101810803B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1225829A (en) * | 1998-12-28 | 1999-08-18 | 张芳芳 | Chinese preparatory medicine for treating haematuria, urinary protein and urinary obstruction |
| CN1689615A (en) * | 2004-04-21 | 2005-11-02 | 范崔生 | Bleeding arresting Chinese medicinal composition and its preparation method |
| CN101623431A (en) * | 2008-07-08 | 2010-01-13 | 张成赟 | Chinese medicinal composition for treating hematuria |
| CN101480457A (en) * | 2008-12-19 | 2009-07-15 | 重庆市合川区生产力促进中心 | Chinese medicinal composition for treating hematuria |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102228633B (en) * | 2011-06-24 | 2012-09-05 | 暨南大学 | Traditional Chinese medicine for treating blood heat and toxic type nosebleed of children and preparation method thereof |
| CN102228633A (en) * | 2011-06-24 | 2011-11-02 | 暨南大学 | Traditional Chinese medicine for treating blood heat and toxic type nosebleed of children and preparation method thereof |
| CN102908467A (en) * | 2011-08-04 | 2013-02-06 | 孙斌 | Traditional Chinese medicine for treating hematuria |
| CN102526413B (en) * | 2011-12-23 | 2013-07-10 | 鞠富霞 | Bladder care irrigation solution and preparation method thereof |
| CN102526413A (en) * | 2011-12-23 | 2012-07-04 | 鞠富霞 | Bladder care irrigation solution and preparation method thereof |
| CN102793902A (en) * | 2012-08-03 | 2012-11-28 | 郭卫东 | Preparation method for traditional Chinese medicine used for treatment of kidney and yin deficient type acute glomerulonephritis |
| CN102836352A (en) * | 2012-09-10 | 2012-12-26 | 曹培琳 | Medicament for treating hemorrhagic disease |
| CN102988800A (en) * | 2012-10-30 | 2013-03-27 | 严中明 | Traditional Chinese medicine composition for treating hematuria and use method thereof |
| CN102988706A (en) * | 2012-10-30 | 2013-03-27 | 严中明 | Prescription of traditional Chinese medicine for treating hematuria |
| JP2014159408A (en) * | 2013-01-22 | 2014-09-04 | Kao Corp | Overactive bladder preventing or improving agent |
| CN103330876A (en) * | 2013-07-19 | 2013-10-02 | 苏州市天灵中药饮片有限公司 | Decoction for curing cystitis |
| CN103550641A (en) * | 2013-11-13 | 2014-02-05 | 杨玉贵 | Kidney essence pill formula for treating chronic pyelonephritis and preparation method of kidney essence pill |
| CN104027617A (en) * | 2014-05-15 | 2014-09-10 | 当涂县科辉商贸有限公司 | Traditional Chinese medicine composition for treating urinary tract infection |
| CN104207130A (en) * | 2014-09-16 | 2014-12-17 | 四川众鼎中药发展有限公司 | Food, health product or pharmaceutical composition with effects of clearing heat and freeing strangury |
| CN104258217A (en) * | 2014-10-16 | 2015-01-07 | 禤燕华 | Traditional Chinese medicine composition for treating hematuria |
| CN104606588A (en) * | 2015-02-03 | 2015-05-13 | 强红艳 | Pharmaceutical composition for treating urinary tract infection |
| CN104606555A (en) * | 2015-02-05 | 2015-05-13 | 范巧兰 | Heat-clearing and toxicity-removing medicine for treating exercise-induced hematuria and preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101810803B (en) | 2011-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101810803B (en) | Chinese medicinal composition for treating hematuria and use of prepared medicine | |
| CN101785823B (en) | Traditional Chinese medicine combination and preparation method for malaise, palpitation and insomnia treatment | |
| CN101869691B (en) | Chinese medicinal composition for treating dysmenorrhea and preparation method thereof | |
| CN101711851B (en) | Traditional Chinese medicine composition for treating symptoms of renal calculus and preparation method thereof | |
| CN101961443B (en) | Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN101810833B (en) | Chinese medicinal composition for treating edema and preparation method thereof | |
| CN101757540A (en) | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof | |
| CN101816742A (en) | Chinese medicinal composition for treating hemorrhoids and preparation method thereof | |
| CN101966301A (en) | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof | |
| CN101810816B (en) | Chinese medicinal composition for treating abnormal vaginal discharge and preparation method thereof | |
| CN101757433A (en) | Traditional Chinese medicine composition for treating acute hepatitis and preparation method thereof | |
| CN101816770A (en) | Chinese medicinal composition for treating diabetes and preparation method thereof | |
| CN101810800A (en) | Chinese medicinal composition for treating skin itch and preparation method thereof | |
| CN101766789B (en) | Chinese medicine composite for treating appendicitis and preparation method thereof | |
| CN101670055A (en) | Traditional Chinese medicine composition for treating disease of pyelonephritis and preparation method | |
| CN101961479A (en) | Chinese medicinal composition for treating bellyache and preparation method thereof | |
| CN101773634A (en) | Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof | |
| CN101780253B (en) | Traditional Chinese medicine compound for treating intestinal abscess and preparation method thereof | |
| CN101797352B (en) | Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN101961480A (en) | Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof | |
| CN101757562A (en) | Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof | |
| CN101829308A (en) | Traditional Chinese medicine combination for treating amenorrhea and preparation method thereof | |
| CN101843872B (en) | Chinese medicinal composition for treating turbid urine and preparation method thereof | |
| CN101837113A (en) | Chinese medicinal composition for curing fever during menstruation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111109 Termination date: 20130525 |